Commonwealth Equity Services’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RPRX
Commonwealth Equity Services's RPRX Position: Q2 2026 in Review
Commonwealth Equity Services increased its Royalty Pharma (RPRX) stake by 11% in Q2 2026, buying an estimated $154K and bringing the position to 29,117 shares worth $1.63M. The position accounts for ﹤0.01% of the portfolio, ranked #2307.
Commonwealth Equity Services first reported a position in RPRX in Q1 2023 and has held it in 6 quarters since. 642 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.
- Commonwealth Equity Services held 29,117 shares of Royalty Pharma worth $1.63M as of Q2 2026.
- Commonwealth Equity Services bought 2,957 Royalty Pharma shares in Q2 2026, an estimated $154K.
- Royalty Pharma made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q2 2026, its #2307 holding.
- Commonwealth Equity Services first reported a position in Royalty Pharma in Q1 2023 and has held it in 6 quarters since.
- 642 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.
Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.